4-(1H-1,2,4-Triazol-1-yl)butan-2-one

Catalog No.: 
ACLUMF831
CAS No.: 
884497-49-8
Molecular Formula: 
C6H9N3O
Molecular Weight: 
139.16
4-(1H-1,2,4-Triazol-1-yl)butan-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$120.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(1H-1,2,4-Triazol-1-yl)butan-2-one
IUPAC Name4-(1H-1,2,4-triazol-1-yl)butan-2-one
MDL No.MFCD05863685
Molecular FormulaC6H9N3O
Molecular Weight139.16
SMILESCC(CCN1N=CN=C1)=O
InChI KeyYEOXPHBIXHBTOZ-UHFFFAOYSA-N
Synonym4-(1H-1,2,4-triazol-1-yl)butan-2-one;UKRORGSYN-BB BBV-229891;4-(1H-1,2,4-triazol-1-yl)butan-2-one(SALTDATA: FREE);2-Butanone, 4-(1H-1,2,4-triazol-1-yl)-
CAS No.884497-49-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLUMF831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBSYZ572 route compound structure diagram
    ACBSYZ57241253-21-8In Stock
  4. Then
  5. ACLUMF831 route product structure diagram
    ACLUMF831884497-49-8
Inquiry

2. ACLUMF831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZLSV654 route compound structure diagram
    ACZLSV65428509-46-8
  2. Plus
  3. ACBSYZ572 route compound structure diagram
    ACBSYZ57241253-21-8In Stock
  4. Then
  5. ACLUMF831 route product structure diagram
    ACLUMF831884497-49-8
Inquiry

3. ACLUMF831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLUMF831 route product structure diagram
    ACLUMF831884497-49-8
Inquiry

Comments (0)